Alex Vandevere
About Alex Vandevere
Alex Vandevere is the Director of U.S. Cell Therapy, Franchise Marketing at Bristol Myers Squibb, with extensive experience in digital marketing strategies within the biopharmaceutical sector.
Title and Current Position
Alex Vandevere is currently serving as the Director, U.S. Cell Therapy, Franchise Marketing at Bristol Myers Squibb. In this role, Alex oversees marketing strategies and initiatives focused on cell therapy products within the U.S. market. This position highlights Alex's expertise in the biopharmaceutical sector, particularly in the novel and rapidly evolving field of cell therapy.
Professional Background
Alex Vandevere has a rich professional background with significant roles across multiple organizations. Prior to the current role, Alex worked as Associate Director, US Oncology Marketing, Melanoma at Bristol Myers Squibb from 2021 to 2022 in Princeton, NJ. From 2018 to 2021, Alex was the Associate Director of Immunology Marketing at Bristol Myers Squibb in Lawrenceville, NJ. Before this, Alex was an Independent Consultant at Clear Digital Advisors from 2015 to 2017 in Radnor, PA. Further back, Alex served as the Senior Vice President of Marketing at The Institutes from 2011 to 2015 in Malvern, PA. Additionally, notable roles include SVP, Strategic Development at Evoke Health, and Senior Marketing Strategist and Group Director at Cadient.
Education and Credentials
Alex Vandevere holds an Executive Development Program certificate in Marketing Strategy, Leadership, Strategy & Innovation from The Wharton School, completed between 2014 and 2015. Additionally, Alex earned a Bachelor of Science in Telecommunications from Kutztown University of Pennsylvania, graduating in 1990.
Expertise in Biopharmaceutical Marketing
Alex Vandevere has garnered extensive experience in digital marketing strategies within the biopharmaceutical sector. Alex’s proficiency is underscored by a strong background in strategic marketing operations, particularly within the healthcare industry. This expertise played a pivotal role in various capacities, including significant contributions to brand marketing initiatives for cell therapy products at Bristol Myers Squibb.